Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

We recently published 10 Big Names Bleed Double Digits. Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is one of the ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals stock sold off on two pipeline disappointments. The biotech company continues to grow with promising ...

Professional Analyst Ratings for Vertex Pharmaceuticals A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $476.67.

However, Vertex Pharmaceuticals has entered a new era, one where it has a more diversified lineup. Since 2023, it has earned approval for Casgevy, a medicine that treats two blood-related ...